These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7542393)

  • 1. Retarded acquisition of a temporal discrimination following destruction of noradrenergic neurones by systemic treatment with DSP4.
    Ho MY; Velazquez Martinez DN; Lopez Cabrera M; al-Zahrani SS; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1995 Apr; 118(3):332-7. PubMed ID: 7542393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destruction of central noradrenergic neurones with DSP4 impairs the acquisition of temporal discrimination but does not affect memory for duration in a delayed conditional discrimination task.
    al-Zahrani SS; al-Ruwaitea AS; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1997 Mar; 130(2):166-73. PubMed ID: 9106915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of destruction of noradrenergic neurones with DSP4 on performance on a free-operant timing schedule.
    Al-Zahrani SS; Al-Ruwaitea AS; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1998 Apr; 136(3):235-42. PubMed ID: 9566808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated acquisition of a temporal discrimination following destruction of the ascending 5-hydroxytryptaminergic pathways.
    Graham S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1994 Nov; 116(3):373-8. PubMed ID: 7534424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSP4 and Herrnstein's equation: further evidence for a role of noradrenaline in the maintenance of operant behaviour by positive reinforcement.
    Morley MJ; Shah K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1988; 96(4):551-6. PubMed ID: 3149780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of destruction of the 5-hydroxytryptaminergic pathways on temporal memory: quantitative analysis with a delayed interval bisection task.
    al-Zahrani SS; Ho MY; al-Ruwaitea AS; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1997 Jan; 129(1):48-55. PubMed ID: 9122363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on timing behaviour investigated with an interval bisection task.
    Morrissey G; Wogar MA; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1993; 112(1):80-5. PubMed ID: 7871013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the ascending 5-hydroxytryptaminergic pathways in timing behaviour: further observations with the interval bisection task.
    Ho MY; al-Zahrani SS; Velazquez Martinez DN; Lopez Cabrera M; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1995 Jul; 120(2):213-9. PubMed ID: 7480555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.
    Archer T; Jonsson G; Ross SB
    Br J Pharmacol; 1984 May; 82(1):249-57. PubMed ID: 6733355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of brain norepinephrine: differential influence on anxiolyic treatment effects.
    Fontana DJ; McMiller LV; Commissaris RL
    Psychopharmacology (Berl); 1999 Apr; 143(2):197-208. PubMed ID: 10326783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSP4 (N-2-chloroethyl-N-ethyl-2-bromobenzylamine), a new noradrenaline neurotoxin, and stimulus conditions affecting acquisition of two-way active avoidance.
    Archer T
    J Comp Physiol Psychol; 1982 Jun; 96(3):476-90. PubMed ID: 7096684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of d-amphetamine on performance on two operant timing schedules.
    Chiang TJ; Al-Ruwaitea AS; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Jun; 150(2):170-84. PubMed ID: 10907670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neurotoxin DSP4 on EEG power spectra in the rat acute model of epilepsy.
    Culić M; Saponjić J; Janković B; Udović S; Popović S; Rakić L
    Neurosci Lett; 1995 Aug; 196(1-2):49-52. PubMed ID: 7501254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylphenidate on attention in Wistar rats treated with the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4).
    Hauser J; Reissmann A; Sontag TA; Tucha O; Lange KW
    J Neural Transm (Vienna); 2017 May; 124(5):643-654. PubMed ID: 28110352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of the noradrenergic system with DSP4 potentiates the behavioral effects of MK-801 in rats.
    Hatip-Al-Khatib I; Bolukbasi F
    Pharmacol Biochem Behav; 1999 Feb; 62(2):233-7. PubMed ID: 9972689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
    Prieto M; Giralt MT
    Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat.
    Moran PM; LeMaître MH; Philouze V; Reymann JM; Allain H; Leonard BE
    Brain Res; 1992 Nov; 595(2):327-33. PubMed ID: 1281740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atomoxetine on attention in Wistar rats treated with the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4).
    Hauser J; Reissmann A; Sontag TA; Tucha O; Lange KW
    Atten Defic Hyperact Disord; 2017 Dec; 9(4):253-262. PubMed ID: 28293899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aziridinium derivative of DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) accelerates the beating rate of isolated rat atria by enhancing the spontaneous release of noradrenaline.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):396-402. PubMed ID: 3431596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.